PTSD: Clinical Trials

4 trials for PTSD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 32Unknown 2

Follow PTSD: new trials by email Literature Review of PTSD trials Research Report on PTSD

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
Glecaprevir/pibrentasvir, Placebo - PTSD
Phase 2 / Phase 3UnknownWhite River Junction Veterans Affairs Medical Center922023-12-182025-04-24
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
Prolonged exposure therapy, MDMA, Niacin - PTSD, Alcohol Use Disorder
Phase 2UnknownUniversity of Sydney1202023-09-192023-11-07
Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans
Psilocybin - PTSD
Phase 2UnknownCombat Stress82023-06-012023-05-25
Psycho-educational Tool to Prevent Psychological Sequelae Following Paediatric Intensive Care Unit Admission
Age-specific information booklet and targeted telephone call - PTSD
Phase 2 / Phase 3UnknownImperial College Healthcare NHS Trust2882021-07-012022-03-24

Narrower conditions

Stress Disorders, Post-Traumatic (4)  ·  Alcoholism (1)  ·  Hepatitis C (1)

Broader conditions

Mental Disorders (4)  ·  Stress Disorders, Traumatic (4)  ·  Trauma and Stressor Related Disorders (4)  ·  Alcohol-Related Disorders (1)  ·  Blood-Borne Infections (1)  ·  Chemically-Induced Disorders (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  RNA Virus Infections (1)  ·  Substance-Related Disorders (1)

Interventions

N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Niacin (1)  ·  Niacinamide (1)  ·  Psilocybin (1)  ·  glecaprevir and pibrentasvir (1)

Sponsors

Combat Stress (1)  ·  Imperial College Healthcare NHS Trust (1)  ·  University of Sydney (1)  ·  White River Junction Veterans Affairs Medical Center (1)

Countries

United Kingdom (2)  ·  Australia (1)  ·  United States (1)

Top investigators

Bradley V Watts, MD, MPH (1)  ·  Kirsten C Morley, PhD (1)  ·  Prof. Dominic Murphy (1)  ·  Simon Nadel, MBBS (1)

Results publications

PMID 41015488, PMID 42409408